John R Prowle1, Ivana Kolic2, Jeremy Purdell-Lewis2, Rachelle Taylor2, Rupert M Pearse3, Christopher J Kirwan4. 1. Adult Critical Care Unit and Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom; and William Harvey Research Institute, Queen Mary University of London, London, United Kingdom john.prowle@bartshealth.nhs.uk. 2. Adult Critical Care Unit and. 3. Adult Critical Care Unit and William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. 4. Adult Critical Care Unit and Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom; and William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Abstract
BACKGROUND AND OBJECTIVES: AKI is a risk factor for development or worsening of CKD. However, diagnosis of renal dysfunction by serum creatinine could be confounded by loss of muscle mass and creatinine generation after critical illness. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A retrospective, single center analysis of serum in patients surviving to hospital discharge with an intensive care unit admission of 5 or more days between 2009 and 2011 was performed. RESULTS: In total, 700 cases were identified, with a 66% incidence of AKI. In 241 patients without AKI, creatinine was significantly lower (P<0.001) at hospital discharge than admission (median, 0.61 versus 0.88 mg/dl; median decrease, 33%). In 160 patients with known baseline, discharge creatinine was significantly lower than baseline in all patients except those patients with severe AKI (Kidney Disease Improving Global Outcomes category 3), who had no significant difference. In a multivariable regression model, median duration of hospitalization was associated with a predicted 30% decrease (95% confidence interval, 8% to 45%) in creatinine from baseline in the absence of AKI; after allowing for this effect, AKI was associated with a 29% (95% confidence interval, 10% to 51%) increase in predicted hospital discharge creatinine. Using a similar model to exclude the confounding effect of prolonged major illness on creatinine, 148 of 700 patients (95% confidence interval, 143 to 161) would have eGFR<60 ml/min per 1.73 m(2) at hospital discharge compared with only 63 of 700 patients using eGFR based on unadjusted hospital creatinine (a 135% increase in potential CKD diagnoses; P<0.001). CONCLUSION: Critical illness is associated with significant falls in serum creatinine that persist to hospital discharge, potentially causing inaccurate assessment of renal function at discharge, particularly in survivors of AKI. Prospective measurements of GFR and creatinine generation are required to confirm the significance of these findings.
BACKGROUND AND OBJECTIVES: AKI is a risk factor for development or worsening of CKD. However, diagnosis of renal dysfunction by serum creatinine could be confounded by loss of muscle mass and creatinine generation after critical illness. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A retrospective, single center analysis of serum in patients surviving to hospital discharge with an intensive care unit admission of 5 or more days between 2009 and 2011 was performed. RESULTS: In total, 700 cases were identified, with a 66% incidence of AKI. In 241 patients without AKI, creatinine was significantly lower (P<0.001) at hospital discharge than admission (median, 0.61 versus 0.88 mg/dl; median decrease, 33%). In 160 patients with known baseline, discharge creatinine was significantly lower than baseline in all patients except those patients with severe AKI (Kidney Disease Improving Global Outcomes category 3), who had no significant difference. In a multivariable regression model, median duration of hospitalization was associated with a predicted 30% decrease (95% confidence interval, 8% to 45%) in creatinine from baseline in the absence of AKI; after allowing for this effect, AKI was associated with a 29% (95% confidence interval, 10% to 51%) increase in predicted hospital discharge creatinine. Using a similar model to exclude the confounding effect of prolonged major illness on creatinine, 148 of 700 patients (95% confidence interval, 143 to 161) would have eGFR<60 ml/min per 1.73 m(2) at hospital discharge compared with only 63 of 700 patients using eGFR based on unadjusted hospital creatinine (a 135% increase in potential CKD diagnoses; P<0.001). CONCLUSION: Critical illness is associated with significant falls in serum creatinine that persist to hospital discharge, potentially causing inaccurate assessment of renal function at discharge, particularly in survivors of AKI. Prospective measurements of GFR and creatinine generation are required to confirm the significance of these findings.
Authors: Edward D Siew; T Alp Ikizler; Michael E Matheny; Yaping Shi; Jonathan S Schildcrout; Ioana Danciu; Jamie P Dwyer; Manakan Srichai; Adriana M Hung; James P Smith; Josh F Peterson Journal: Clin J Am Soc Nephrol Date: 2012-03-15 Impact factor: 8.237
Authors: Cherry Mammen; Abdullah Al Abbas; Peter Skippen; Helen Nadel; Daniel Levine; J P Collet; Douglas G Matsell Journal: Am J Kidney Dis Date: 2011-12-28 Impact factor: 8.860
Authors: Jason Jones; John Holmen; Jennifer De Graauw; Anna Jovanovich; Sid Thornton; Michel Chonchol Journal: Am J Kidney Dis Date: 2012-04-27 Impact factor: 8.860
Authors: Wolfgang Gruther; Thomas Benesch; Carina Zorn; Tatjana Paternostro-Sluga; Michael Quittan; Veronika Fialka-Moser; Christian Spiss; Franz Kainberger; Richard Crevenna Journal: J Rehabil Med Date: 2008-03 Impact factor: 2.912
Authors: Kent Doi; Peter S T Yuen; Christoph Eisner; Xuzhen Hu; Asada Leelahavanichkul; Jürgen Schnermann; Robert A Star Journal: J Am Soc Nephrol Date: 2009-04-23 Impact factor: 10.121
Authors: Lowell J Lo; Alan S Go; Glenn M Chertow; Charles E McCulloch; Dongjie Fan; Juan D Ordoñez; Chi-yuan Hsu Journal: Kidney Int Date: 2009-07-29 Impact factor: 10.612
Authors: Edward D Siew; Michael E Matheny; T Alp Ikizler; Julie B Lewis; Randolph A Miller; Lemuel R Waitman; Alan S Go; Chirag R Parikh; Josh F Peterson Journal: Kidney Int Date: 2009-12-30 Impact factor: 10.612
Authors: Jürgen Floege; Robert H Mak; Bruce A Molitoris; Giuseppe Remuzzi; Pierre Ronco Journal: Nat Rev Nephrol Date: 2015-09-29 Impact factor: 28.314
Authors: Ryan W Haines; Parjam Zolfaghari; Yize Wan; Rupert M Pearse; Zudin Puthucheary; John R Prowle Journal: Intensive Care Med Date: 2019-09-17 Impact factor: 17.440
Authors: Khaled Abdel-Kader; Timothy D Girard; Nathan E Brummel; Christina T Saunders; Jeffrey D Blume; Amanda J Clark; Andrew J Vincz; E Wesley Ely; James C Jackson; Susan P Bell; Kristin R Archer; T Alp Ikizler; Pratik P Pandharipande; Edward D Siew Journal: Crit Care Med Date: 2018-05 Impact factor: 7.598
Authors: David G Warnock; T Clark Powell; Edward D Siew; John P Donnelly; Henry E Wang; Ravindra L Mehta Journal: Nephron Date: 2016-07-26 Impact factor: 2.847